Columbia Herbert Irving Cancer Center – Lymphoma Program is a cancer treatment center located in New York, New York, specializing in the diagnosis and management of lymphoma. Situated at 161 Fort Washington Avenue, the center serves patients throughout the region with a focus on providing comprehensive care tailored to the complexities of lymphoma. Its multidisciplinary team integrates clinical expertise and advanced treatment modalities to address both common and rare forms of lymphoma.
The center’s approach involves collaboration among oncologists, hematologists, radiologists, and support staff to develop individualized treatment plans that consider the patient’s specific disease characteristics and overall health. By utilizing the latest diagnostic tools and therapeutic options, including chemotherapy, immunotherapy, and targeted therapies, the program aims to optimize patient outcomes while managing side effects and maintaining quality of life.
Beyond patient care, Columbia Herbert Irving Cancer Center – Lymphoma Program contributes to ongoing research efforts to better understand lymphoma biology and improve treatment protocols. The integration of clinical trials within the program allows access to emerging therapies and innovations in cancer care. As part of a larger academic medical institution, the center also supports education and training initiatives to advance expertise in oncology and hematology.
Located in New York City, the cancer treatment center is accessible to a diverse patient population and collaborates with other healthcare providers and community resources to ensure comprehensive support services. The program’s commitment to combining clinical excellence with research and education makes it a key resource for lymphoma patients seeking specialized care in the New York metropolitan area.
